{
  "version": 0,
  "last_updated": "2026-02-01T17:58:55.968876",
  "rules": [
    {
      "rule_id": "STROKE_BP",
      "name": "Stroke Patient BP Management",
      "condition": {},
      "action": "BLOCK",
      "severity": "critical",
      "guideline_source": "AHA Stroke Guidelines 2019",
      "explanation_template": "Aggressive BP lowering (target <110) contraindicated in stroke history"
    },
    {
      "rule_id": "RENAL_NSAID",
      "name": "Renal Impairment NSAID Contraindication",
      "condition": {},
      "action": "BLOCK",
      "severity": "critical",
      "guideline_source": "KDIGO CKD Guidelines",
      "explanation_template": "NSAIDs contraindicated with eGFR <30"
    },
    {
      "rule_id": "HYPERKALEMIA_K",
      "name": "Hyperkalemia Potassium Restriction",
      "condition": {},
      "action": "BLOCK",
      "severity": "critical",
      "guideline_source": "KDIGO AKI Guidelines",
      "explanation_template": "Potassium supplementation contraindicated with K+ >5.5"
    },
    {
      "rule_id": "BRADY_BETABLOCK",
      "name": "Bradycardia Beta Blocker Warning",
      "condition": {},
      "action": "WARN",
      "severity": "warning",
      "guideline_source": "AHA Arrhythmia Guidelines",
      "explanation_template": "Caution with beta blockers in bradycardia (HR <50)"
    },
    {
      "rule_id": "CUSTOM_DKA_AGGRESSIVE",
      "name": "Aggressive DKA Treatment",
      "condition": {
        "glucose": [
          ">",
          300
        ],
        "ph": [
          "<",
          7.25
        ]
      },
      "action": "Initiate aggressive fluid resuscitation and insulin drip",
      "severity": "critical",
      "guideline_source": "Hospital Protocol v2.1",
      "explanation_template": "DKA with pH < 7.25 requires aggressive treatment"
    }
  ]
}